Document Type : Original Research


1 Dept. of Pathology, Tehran University of Medical Sciences, Tehran, Iran

2 Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran

3 Dept. of Gastroenterology and Hepatology, Tehran University of Medical Sciences, Tehran, Iran


Background and Objectives: HBV DNA monitoring is important in management of chronic viral hepatitis B infection. HBV DNA measurements are carried out over period of months to years. So the analytical system must be stable and reproducible. The aim of this study was to determine the performance characteristics and to plan a statistical quality control system of a laboratory-developed real-time quantitative PCR assay for HBV DNA quantification. Methods: Values of systematic and random error at two clinical decision points;4.2 Log IU/mL (20000 IU/mL) and 3.2 Log IU/mL (2000 IU/mL) were determined. Candidate quality control procedures were selected and performance of the method by application of normalized operational process specification (OPSpecs) charts was determined. Results: The performance of the assay at level of 4.2 Log IU/mL and 3.2 Log IU/mL were excellent and good respectively. Moreover, a13.5S rule with two measurements offered 90% probability of error detection at level of 4.2 Log IU/mL, while no rule offered 90% probability of error detection at level of 3.2 Log IU/mL. Conclusion: Minimizing the formation of primer-dimer and nonspecific products and concentrating the target DNA during the purification process are proposed for accurate quantitative PCR particularly when CT values are high.


  1. Abe A, Inoue K, Tanaka T, Kato J, Kajiyama N, Kawaguchi R, et al. Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol 1999;37(9):2899-903.
  2. Mackay IM. Real-time PCR in the microbiology laboratory. Clin Microbiol Infect 2004;10(3):190-212.
  3. Gish RG, Locarnini SA. Chronic Hepatitis B: Current Testing Strategies. Clin Gastroenterol Hepatol 2006;4(6):666–76.
  4. Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 2006;19(1):165-256.
  5. Nolte FS, Arbique J, Cockerill F. Molecular Diagnostic Methods for Infectious Diseases; Approved Guideline. 2nd ed. CLSI guideline MM3- A, 2006..
  6. John B, Henry J. Clinical diagnosis and management by laboratory methods. New York: WB Saunders Company;2012.
  7. Feldman M, Friedman L, Feldman BL. Sleisenger and Fordthans Gastrointestinal and Liver disease. 9th ed. New York:Elsevier Saunders;2010.
  8. Westgard, JO. Charts of operational process specification ("OPSpecs charts") for assessing the precision, accuracy, and quality control needed to satisfy proficiency testing performance criteria. Clin Chem 1992;38:1226-33.
  9. Linnet K, Boyd JC. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed. St. Louis:Elsevier Saunders;2006.
  10. Rundell CA. Upgrading quality control in molecular diagnostics: Traditional QC protocols can be adopted to address gaps in quality assurance for molecular testing, IDV; 2008.
  11. Ling-Liang S, Ming-Tseh L, Michael J, Hafez, Christopher D, Murphy KM, Eshlemen JR. Application of Traditional Clinical Pathology Quality Control Techniques to Molecular Pathology. J Mol Diag 2008; 2(10):142-7.
  12. Longo L, Fauci A, Kasper D, Hauser S, Jamenson L, Loscalzo J. Harrison’s principles of internal medicine 18th ed. New York:Mc-Graw Hill;2011.
  13. Ginzinger DJ. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 2002;30(6):503-12.
  14. Ismail AM, Sivakumar J, Anantharam R, Dayalan S, Samuel P, Fletcher GJ, et al., Performance Characteristics and Comparison of Abbott and artus Real-Time Systems for Hepatitis B Virus DNA Quantification. J Clin Microbiol 2011;49(9):3215-21.
  15. Belinda YL, Brambilla D, Brooks J, Bremer J, Coombs R, Cronin M, et al. Evaluation of a Quality Assurance Program for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma by the AIDS Clinical Trials Group Virology Laboratories. J Clin Microbiol 1996;34(11):2695–701.